ESMO 2024 Insights: Risk Factors for Recurrence and Prognostic Subgroups in Stage I Uterine Leiomyosarcomas - Insights From the Daydream Study | VuMedi

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Risk Factors for Recurrence and Prognostic Subgroups in Stage I Uterine Leiomyosarcomas - Insights From the Daydream Study

By 2024 ESMO Annual Meeting Insights Hub FEATURING Alejandro Gallego

By 2024 ESMO Annual Meeting Insights Hub FEATURING Alejandro Gallego

31 views

October 1, 2024

Comments 0

Login to view comments. Click here to Login